The global cancer biomarkers market size reached US$ 21.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 47.66 Billion by 2027 exhibiting a growth rate (CAGR) of 13.20% during 2022-2027. Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of...